WithdrawnPhase 2NCT00101140

Donor Stem Cell Transplant in Treating Patients With Acute Myeloid Leukemia in Remission

Studying Acute erythroid leukemia

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Eastern Cooperative Oncology Group
Principal Investigator
Mark R. Litzow, MD
Mayo Clinic
Intervention
anti-thymocyte globulin(drug)
Eligibility
18-59 years · All sexes

Collaborators

National Cancer Institute (NCI)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00101140 on ClinicalTrials.gov

Other trials for Acute erythroid leukemia

Additional recruiting or active studies for the same condition.

See all trials for Acute erythroid leukemia →

← Back to all trials